These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11738866)

  • 1. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Dragich J; Schanen C; Tamura M
    Brain Dev; 2001 Dec; 23 Suppl 1():S165-73. PubMed ID: 11738866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M
    J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of Rett syndrome mutations on human MeCP2.
    Yusufzai TM; Wolffe AP
    Nucleic Acids Res; 2000 Nov; 28(21):4172-9. PubMed ID: 11058114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional significance of MeCP2 mutations in patients with Rett syndrome].
    Kudo S
    No To Hattatsu; 2002 May; 34(3):224-9. PubMed ID: 12030011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
    Ballestar E; Yusufzai TM; Wolffe AP
    Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.
    Van den Veyver IB; Zoghbi HY
    Brain Dev; 2001 Dec; 23 Suppl 1():S147-51. PubMed ID: 11738862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
    Nan X; Bird A
    Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
    Shahbazian MD; Zoghbi HY
    Curr Opin Neurol; 2001 Apr; 14(2):171-6. PubMed ID: 11262731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls.
    Evans JC; Archer HL; Whatley SD; Kerr A; Clarke A; Butler R
    Eur J Hum Genet; 2005 Jan; 13(1):124-6. PubMed ID: 15367913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome.
    Chae JH; Hwang YS; Kim KJ
    J Child Neurol; 2002 Jan; 17(1):33-6. PubMed ID: 11913567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rett syndrome: the complex nature of a monogenic disease.
    Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
    J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
    Amano K; Nomura Y; Segawa M; Yamakawa K
    J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
    Amir RE; Zoghbi HY
    Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome.
    Inui K; Akagi M; Ono J; Tsukamoto H; Shimono K; Mano T; Imai K; Yamada M; Muramatsu T; Sakai N; Okada S
    Brain Dev; 2001 Jul; 23(4):212-5. PubMed ID: 11376998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
    Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
    Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
    Braunschweig D; Simcox T; Samaco RC; LaSalle JM
    Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rett syndrome: a surprising result of mutation in MECP2.
    Dragich J; Houwink-Manville I; Schanen C
    Hum Mol Genet; 2000 Oct; 9(16):2365-75. PubMed ID: 11005791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.